Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fisher Wallace Neurostimulation & Depression Study
Sponsor: ProofPilot
Summary
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.
Official title: Neurostimulation & Depression Study
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
175
Start Date
2020-08-24
Completion Date
2021-11-30
Last Updated
2021-02-11
Healthy Volunteers
Yes
Conditions
Interventions
Fisher Wallace Cranial Electrotherapy Stimulator Device
Fisher Wallace Stimulator®, a patented cranial electrotherapy stimulation device that was cleared by the FDA in 1991 for the treatment of depression, anxiety and insomnia.
Locations (1)
ProofPilot (Remote Virtual Trial)
New York, New York, United States